News Releases - MedAvail

Year

May 18, 2023

MedAvail Reports First Quarter 2023 Financial Results

PHOENIX , May 18, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the first quarter ended March 31, 2023 . “During the first quarter, we made good progress toward our mission of becoming a

May 18, 2023

MedAvail to Report First Quarter 2023 Financial Results on May 18

Management to host investor conference call and webcast at 4:30pm EDT today PHOENIX , May 18, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that the Company will announce financial results for the first

May 15, 2023

MedAvail Postpones Reporting of First Quarter 2023 Financial Results

PHOENIX , May 15, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced today that it is postponing its scheduled earnings release and conference call for the quarter ended March 31, 2023 previously

April 13, 2023

MedAvail Reports Fourth Quarter and Full-Year 2022 Financial Results

PHOENIX , April 13, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the three months and full-year ended December 31, 2022 . “Since assuming the role of CEO in January 2022 , I have been

April 12, 2023

MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on April 13

Management to host investor conference call and webcast at 4:30pm EDT on that day PHOENIX , April 12, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that the Company will announce financial results for the

March 30, 2023

MedAvail Postpones Reporting of Fourth Quarter and FY 2022 Financial Results

PHOENIX , March 30, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced today that it is postponing its scheduled earnings release and conference call for the fourth quarter and full-year ended December

March 16, 2023

MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on March 30

Management to host investor conference call and webcast at 4:30pm ET on that day PHOENIX , March 16, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that the Company will announce financial results for the

March 14, 2023

MedAvail Announces Closing of $16 Million Private Placement

PHOENIX , March 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that on March 13, 2023 , it closed a private placement (the “Offering”) of securities with certain institutional investors pursuant to the

January 26, 2023

MedAvail announces Sale of Pharmacy Assets to CVS Pharmacy

PHOENIX , Jan. 26, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative technology-enabled pharmacy company, today announced it has entered into a definitive agreement with CVS Pharmacy, Inc. , on behalf of itself and its subsidiaries and affiliates (“CVS”),

January 19, 2023

MedAvail announces Strategic Restructuring of Business to Focus on Profitability

Company focusing on innovative technology and exit of pharmacy services Restructuring to further extend capital resources Annual cash burn expected to be reduced by greater than 65% in 2023 Company exploring financing options in connection with business transition PHOENIX, Ariz. , Jan.